Concepedia

Olga Ab

OA

Statistics

Publications

16

Citations

1.3K

H-Index

14

Active since

2004

Affiliations

ImmunoGen (United States)(Current)

Olga Ab is an author at ImmunoGen (United States) specializing in immunology, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2022

16

Publications

16

Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance

Yelena Kovtun, Charlene A. Audette, Michele Mayo et al. · Cancer Research · 2010 · 254 citations

, , +18

Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates

Xiuxia Sun, Jose F. Ponte, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2017 · 242 citations

, , +23

IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors

Olga Ab, Kathleen R. Whiteman, Laura M. Bartle et al. · Molecular Cancer Therapeutics · 2015 · 209 citations

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

Yelena Kovtun, Gregory E. Jones, Sharlene Adams et al. · Blood Advances · 2018 · 174 citations · Full text

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models

Jose F. Ponte, Olga Ab, Leanne Lanieri et al. · Neoplasia · 2016 · 107 citations · Full text

, , +21

1–5 of 16